James A. Bianco
Chairman at Aequus BioPharma, Inc.
James A. Bianco active positions
Companies | Position | Start | End |
---|---|---|---|
Friends of José Carreras International Leukemia Foundation | Director/Board Member | - | - |
Fred Hutchinson Business Alliance | Director/Board Member | - | - |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | Director/Board Member | - | - |
Seattle Police Foundation | Director/Board Member | - | - |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | Chairman | 2009-09-16 | - |
The Leukaemia Foundation | Director/Board Member | 2010-08-17 | - |
Nakea, Inc. | Director/Board Member | 2010-10-27 | - |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | Director/Board Member | - | - |
Seattle Symphony Foundation | Director/Board Member | - | - |
░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ | - | - |
Career history of James A. Bianco
Former positions of James A. Bianco
Companies | Position | Start | End |
---|---|---|---|
░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░ ░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of James A. Bianco
New York University | Undergraduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistics
International
United States | 18 |
Operational
Director/Board Member | 11 |
Corporate Officer/Principal | 3 |
President | 2 |
Sectoral
Consumer Services | 5 |
Commercial Services | 4 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 14 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Nakea, Inc. | |
Veterans Administration Medical Center
Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA. | Health Services |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | Commercial Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
The Leukaemia Foundation | |
Friends of José Carreras International Leukemia Foundation | |
Fred Hutchinson Business Alliance | |
Seattle Police Foundation | Miscellaneous |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Commercial Services |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | Health Services |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | Consumer Services |
Seattle Symphony Foundation | |
TuHURA Biopharma, Inc.
TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | Health Technology |
- Stock Market
- Insiders
- James A. Bianco
- Experience